| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-08 15:36:17 UTC |
|---|
| Updated at | 2022-09-08 15:36:18 UTC |
|---|
| NP-MRD ID | NP0269964 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | n-[(2z)-3-{4-[(3z)-5-{[(1r,5s,7s,9s,11r,13r)-7-methoxy-9-methyl-3-oxo-5-propyl-4,15-dioxabicyclo[9.3.1]pentadecan-13-yl]oxy}-5-oxopent-3-en-1-yl]-1,3-oxazol-2-yl}prop-2-en-1-yl]methoxycarboximidic acid |
|---|
| Description | Neopeltolide belongs to the class of organic compounds known as macrolides and analogues. These are organic compounds containing a lactone ring of at least twelve members. n-[(2z)-3-{4-[(3z)-5-{[(1r,5s,7s,9s,11r,13r)-7-methoxy-9-methyl-3-oxo-5-propyl-4,15-dioxabicyclo[9.3.1]pentadecan-13-yl]oxy}-5-oxopent-3-en-1-yl]-1,3-oxazol-2-yl}prop-2-en-1-yl]methoxycarboximidic acid was first documented in 2016 (PMID: 27023567). Based on a literature review a significant number of articles have been published on Neopeltolide (PMID: 32631529) (PMID: 31259993) (PMID: 30919530) (PMID: 30794394) (PMID: 30009295) (PMID: 29053565). |
|---|
| Structure | CCC[C@H]1C[C@H](C[C@H](C)C[C@@H]2C[C@H](C[C@H](CC(=O)O1)O2)OC(=O)\C=C/CCC1=COC(\C=C/CN=C(O)OC)=N1)OC InChI=1S/C31H46N2O9/c1-5-9-23-16-24(37-3)14-21(2)15-25-17-26(18-27(40-25)19-30(35)41-23)42-29(34)12-7-6-10-22-20-39-28(33-22)11-8-13-32-31(36)38-4/h7-8,11-12,20-21,23-27H,5-6,9-10,13-19H2,1-4H3,(H,32,36)/b11-8-,12-7-/t21-,23-,24-,25+,26+,27+/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C31H46N2O9 |
|---|
| Average Mass | 590.7140 Da |
|---|
| Monoisotopic Mass | 590.32033 Da |
|---|
| IUPAC Name | N-[(2Z)-3-{4-[(3Z)-5-{[(1R,5S,7S,9S,11R,13R)-7-methoxy-9-methyl-3-oxo-5-propyl-4,15-dioxabicyclo[9.3.1]pentadecan-13-yl]oxy}-5-oxopent-3-en-1-yl]-1,3-oxazol-2-yl}prop-2-en-1-yl]methoxycarboximidic acid |
|---|
| Traditional Name | N-[(2Z)-3-{4-[(3Z)-5-{[(1R,5S,7S,9S,11R,13R)-7-methoxy-9-methyl-3-oxo-5-propyl-4,15-dioxabicyclo[9.3.1]pentadecan-13-yl]oxy}-5-oxopent-3-en-1-yl]-1,3-oxazol-2-yl}prop-2-en-1-yl]methoxycarboximidic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCC[C@H]1C[C@H](C[C@H](C)C[C@@H]2C[C@H](C[C@H](CC(=O)O1)O2)OC(=O)\C=C/CCC1=COC(\C=C/CN=C(O)OC)=N1)OC |
|---|
| InChI Identifier | InChI=1S/C31H46N2O9/c1-5-9-23-16-24(37-3)14-21(2)15-25-17-26(18-27(40-25)19-30(35)41-23)42-29(34)12-7-6-10-22-20-39-28(33-22)11-8-13-32-31(36)38-4/h7-8,11-12,20-21,23-27H,5-6,9-10,13-19H2,1-4H3,(H,32,36)/b11-8-,12-7-/t21-,23-,24-,25+,26+,27+/m0/s1 |
|---|
| InChI Key | YRSJLYCTJWNTMF-KXXBBFITSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as macrolides and analogues. These are organic compounds containing a lactone ring of at least twelve members. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Macrolides and analogues |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Macrolides and analogues |
|---|
| Alternative Parents | |
|---|
| Substituents | - Macrolide
- 2,4-disubstituted 1,3-oxazole
- Fatty acid ester
- Dicarboxylic acid or derivatives
- Oxane
- Fatty acyl
- Heteroaromatic compound
- Methylcarbamate
- Azole
- Oxazole
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- Carbamic acid ester
- Carboxylic acid ester
- Lactone
- Ether
- Azacycle
- Dialkyl ether
- Carboxylic acid derivative
- Oxacycle
- Organoheterocyclic compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Organic oxide
- Carbonyl group
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Xiong MQ, Chen T, Wang YX, Zhu XL, Yang GF: Design and synthesis of potent inhibitors of bc1 complex based on natural product neopeltolide. Bioorg Med Chem Lett. 2020 Aug 15;30(16):127324. doi: 10.1016/j.bmcl.2020.127324. Epub 2020 Jun 8. [PubMed:32631529 ]
- Yanagi S, Sugai T, Noguchi T, Kawakami M, Sasaki M, Niwa S, Sugimoto A, Fuwa H: Fluorescence-labeled neopeltolide derivatives for subcellular localization imaging. Org Biomol Chem. 2019 Jul 17;17(28):6771-6776. doi: 10.1039/c9ob01276a. [PubMed:31259993 ]
- Li J, Preinfalk A, Maulide N: Diastereo- and Enantioselective Access to Stereotriads through a Flexible Coupling of Substituted Aldehydes and Alkenes. Angew Chem Int Ed Engl. 2019 Apr 23;58(18):5887-5890. doi: 10.1002/anie.201900801. Epub 2019 Mar 27. [PubMed:30919530 ]
- Zhu XL, Zhang R, Wu QY, Song YJ, Wang YX, Yang JF, Yang GF: Natural Product Neopeltolide as a Cytochrome bc1 Complex Inhibitor: Mechanism of Action and Structural Modification. J Agric Food Chem. 2019 Mar 13;67(10):2774-2781. doi: 10.1021/acs.jafc.8b06195. Epub 2019 Mar 4. [PubMed:30794394 ]
- Larsen EM, Chang CF, Sakata-Kato T, Arico JW, Lombardo VM, Wirth DF, Taylor RE: Conformation-guided analogue design identifies potential antimalarial compounds through inhibition of mitochondrial respiration. Org Biomol Chem. 2018 Aug 1;16(30):5403-5406. doi: 10.1039/c8ob01257a. [PubMed:30009295 ]
- Fuwa H, Sato M: A Synthetic Analogue of Neopeltolide, 8,9-Dehydroneopeltolide, Is a Potent Anti-Austerity Agent against Starved Tumor Cells. Mar Drugs. 2017 Oct 20;15(10). pii: md15100320. doi: 10.3390/md15100320. [PubMed:29053565 ]
- Fuwa H: Contemporary Strategies for the Synthesis of Tetrahydropyran Derivatives: Application to Total Synthesis of Neopeltolide, a Marine Macrolide Natural Product. Mar Drugs. 2016 Mar 25;14(4). pii: md14040065. doi: 10.3390/md14040065. [PubMed:27023567 ]
- Hari TP, Wilke BI, Davey JA, Boddy CN: Diastereoseletive Transannular Oxa-Conjugate Addition Generates the 2,6-cis-Disubstituted Tetrahydropyran of Neopeltolide. J Org Chem. 2016 Jan 15;81(2):415-23. doi: 10.1021/acs.joc.5b02014. Epub 2015 Dec 29. [PubMed:26675500 ]
- Nakazato K, Oda M, Fuwa H: Total Synthesis of (+)-Neopeltolide by the Macrocyclization/Transannular Pyran Cyclization Strategy. Org Lett. 2022 Jun 10;24(22):4003-4008. doi: 10.1021/acs.orglett.2c01429. Epub 2022 Jun 1. [PubMed:35649194 ]
- Zhang J, Chen XW, Shu LS, Liu CD: The correlation and role analysis of SLC30A1 and SLC30A10 in cervical carcinoma. J Cancer. 2022 Jan 4;13(3):1031-1047. doi: 10.7150/jca.56777. eCollection 2022. [PubMed:35154468 ]
- LOTUS database [Link]
|
|---|